TTK and cancer: Mps1 overexpression has been reported in aggressive types of cancer of poor prognosis such as glioblastomas, triple-negative breast cancer and pancreatic cancer [59,60] and it has been suggested that this may be due to abnormal activation of the SAC and the induction of genome instability [59].